Nucleolar prominence as a diagnostic variable in prostatic carcinoma
โ Scribed by Pond R. Kelemen; Robert J. Buschmann; Paul Weisz-Carrington
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 326 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prostatic-specific antigen (PSA) is regarded as a specific marker secreted by normal and neoplastic acinar epithelial cells of the prostate gland; its detection by immunocytochemistry has been accepted as an indication of metastatic prostate cancer. This is ascribed to the commonly held belief that
## Background: Bone scans, widely used for the detection of bone metastases from prostate carcinoma, can neither quantitate metastatic lesions nor detect osteolytic lesions. ## Methods: Serum concentrations of the carboxyterminal propeptide of type i procollagen (picp), the carboxyterminal pyridi
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is an activating ligand for the EGF receptor (HER1/ErbB1) and the high-affinity receptor for diphtheria toxin (DT) in its transmembrane form (proHB-EGF). HB-EGF was immunolocalized within human benign and malignant prostatic tissues